{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["25(21)"],"submitter":["Adamska P"],"pubmed_abstract":["The formation of an oroantral communication (OAC) or fistula (OAF) is a rare complication resulting from the presence of processes in the lateral parts of the maxilla or for iatrogenic reasons. The most common causes of OAC or OAF are tooth extraction with periapical lesions. The aims of this systematic review were to assess the use of platelet-derived preparations rich in growth factors in the treatment of OAC or OAF, to determine the success of treating the communication or fistula, as well as impact on postoperative complications and the course of healing. The study was performed following PRISMA guidelines (PROSPERO: CRD42024570758). The inclusion criteria were as follows: at least ten patients, the presence of oroantral communication or oroantral fistula, treatment with platelet-deriv"],"journal":["International journal of molecular sciences"],"pagination":["11507"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11546229"],"repository":["biostudies-literature"],"pubmed_title":["Treatment of Oroantral Communication and Fistulas with the Use of Blood-Derived Platelet-Rich Preparations Rich in Growth Factors: A Systematic Review."],"pmcid":["PMC11546229"],"pubmed_authors":["Adamska P","Zedler A","Pylinska-Dabrowska D","Bartmanski M","Stasiak M","Kaczoruk-Wieremczuk M","Studniarek M"],"additional_accession":[]},"is_claimable":false,"name":"Treatment of Oroantral Communication and Fistulas with the Use of Blood-Derived Platelet-Rich Preparations Rich in Growth Factors: A Systematic Review.","description":"The formation of an oroantral communication (OAC) or fistula (OAF) is a rare complication resulting from the presence of processes in the lateral parts of the maxilla or for iatrogenic reasons. The most common causes of OAC or OAF are tooth extraction with periapical lesions. The aims of this systematic review were to assess the use of platelet-derived preparations rich in growth factors in the treatment of OAC or OAF, to determine the success of treating the communication or fistula, as well as impact on postoperative complications and the course of healing. The study was performed following PRISMA guidelines (PROSPERO: CRD42024570758). The inclusion criteria were as follows: at least ten patients, the presence of oroantral communication or oroantral fistula, treatment with platelet-deriv","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2025-04-22T19:39:23.594Z","creation":"2025-04-06T02:53:09.961Z"},"accession":"S-EPMC11546229","cross_references":{"pubmed":["39519060"],"doi":["10.3390/ijms252111507"]}}